Innoviva, Inc. Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Innoviva, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2018 to Q1 2024.
  • Innoviva, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $3.24M.
  • Innoviva, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $4.4M, a 82.4% decline from 2022.
  • Innoviva, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was $25M, a 67.3% decline from 2021.
  • Innoviva, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was $76.4M, a 26.5% increase from 2020.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $3.24M +$4.06M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q1 2023 -$812K -$7.67M -112% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q1 2022 $6.86M -$12.9M -65.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $19.7M +$3.8M +23.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 $15.9M +$7.42M +87.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-28
Q1 2019 $8.51M +$8.51M Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q1 2018 $0 Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.